Clinical trials for Cancer in United States

ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer

Study ID: NCT05792566

Sponsor

Connecticut Children's Medical Center

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Study ID: NCT04812366

Sponsor

University of British Columbia

Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing

Study ID: NCT06749366

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Study ID: NCT06090266

Sponsor

OncoResponse, Inc.

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Study ID: NCT05696626

Sponsor

Sermonix Pharmaceuticals Inc.

UPLYFT For Lymphoma Survivors

Study ID: NCT05080166

Sponsor

Dana-Farber Cancer Institute

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Study ID: NCT05800665

Sponsor

Genentech, Inc.

Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer

Study ID: NCT06654466

Sponsor

Nest Genomics

Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Study ID: NCT05618366

Sponsor

Weill Medical College of Cornell University

Conventional Prophylactic Oral Dexamethasone vs Short-course IV Dexamethasone in Paclitaxel Hypersensitivity

Study ID: NCT03598426

Sponsor

Loma Linda University